0000000000267871

AUTHOR

Kalina Kawecka-jaszcz

showing 4 related works from this author

From pioneering to implementing automated blood pressure measurement in clinical practice: Thomas Pickeringʼs legacy

2010

Thomas G. Pickering spent most of his scientific career in carrying out research on clinical hypertension and blood pressure (BP) measurement. In our review of Pickering's seminal work, we first focused on white-coat hypertension and masked hypertension, two terms that he had introduced. Next, we highlighted the early publications of Pickering on diurnal BP variability and on the clinical application of self-measured BP. Pickering's work inspired many investigators worldwide and constituted a solid basis for further research. Pickering's original ideas led to algorithms for risk stratification involving white-coat hypertension and masked hypertension, diurnal BP variability, and self-measur…

MaleGerontologymedicine.medical_specialtyAmbulatory blood pressureAdolescentScientific careerConditioning ClassicalCardiologyWhite coat hypertension030204 cardiovascular system & hematologyAssessment and DiagnosisHistory 21st Century03 medical and health sciences0302 clinical medicineself-measured blood pressureInternal MedicinemedicineHumansBlood pressure monitoringmasked hypertension030212 general & internal medicineChildIntensive care medicineAdvanced and Specialized Nursingbusiness.industryblood pressureGeneral MedicineBlood Pressure Monitoring AmbulatoryHistory 20th Centurymedicine.diseaseCircadian RhythmClinical PracticeMasked HypertensionBlood pressureCardiovascular DiseasesHypertensionRisk stratificationFemaleCardiology and Cardiovascular Medicinebusinessdiurnal blood pressure variabilitywhite-coat hypertensionBlood Pressure Monitoring
researchProduct

OASIS-HT: design of a pharmacogenomic dose-finding study.

2005

Experimental evidence and observations in humans strongly support an interactive role of mutated α-adducin, sodium (Na+)/potassium (K+)-adenosine triphosphatase (ATPase) activity and endogenous ouabain in Na+homeostasis and the pathogenesis of hypertension. The Ouabain and Adducin for Specific Intervention on Sodium in HyperTension (OASIS-HT) trial is an early Phase II dose-finding study, which will be conducted across 39 European centers. Following a run-in period of 4 weeks without treatment, eligible patients will be randomized to one of five oral doses of rostafuroxin consisting of 0.05, 0.15, 0.5, 1.5, or 5.0 mg/day. Each dose will be compared to a placebo in a double-blind crossover e…

AdultMalemedicine.medical_specialtyRandomizationTime FactorsSystolic hypertensionMolecular ConformationAdministration OralBlood PressurePharmacologyPlaceboOuabainDrug Administration ScheduleDouble-Blind MethodRisk FactorsInternal medicineGeneticsClinical endpointMedicineHumansAndrostanolsOuabainAntihypertensive AgentsPharmacologyCross-Over StudiesDose-Response Relationship Drugbusiness.industryMiddle Agedmedicine.diseaseCrossover studyBlood pressureEndocrinologyTreatment OutcomeHypertensionMolecular MedicineCalmodulin-Binding ProteinsFemalebusinessHomeostasismedicine.drugPharmacogenomics
researchProduct

Morbidity and mortality on combination versus monotherapy in the Systolic Hypertension in Europe Trial

2009

medicine.medical_specialtySystolic hypertensionbusiness.industryEmergency medicinemedicineCardiology and Cardiovascular Medicinemedicine.diseaseIntensive care medicinebusinessInternational Journal of Cardiology
researchProduct

Association of central and peripheral pulse pressure with intermediate cardiovascular phenoytpes

2012

Objective: We assessed the relationship between pulse pressure and intermediate cardiovascular phenotypes in a middle-aged cohort with high prevalence of hypertension. Background: It has been suggested that central pulse pressure (cPP) is a better predictor of cardiovascular outcome than peripheral pulse pressure (pPP), particularly in the elderly. Yet, it is unclear if cPP provides additional prognostic information to pPP in younger individuals. Methods: In 535 individuals we assessed cPP and pPP as well as the intermediate cardiovascular phenotypes pulse wave velocity (PWV; SphygmoCor, Complior, PulsePen), carotid intima-media thickness (C-IMT; carotid ultrasound), left-ventricular mass i…

MalePhysiologyintermediate cardiovascular phenotypesBlood Pressure030204 cardiovascular system & hematologysurrogate markersCohort Studiespressure0302 clinical medicineHeart Ratepulse wave analysis030212 general & internal medicinerisk-factorsstage renal-diseasePulse wave velocitypulse wave analysiMiddle AgedPhenotypePeripheralPulse pressureleft ventricular hypertrophyarterial stiffnessPhenotypeaortic pressureAortic pressureCardiologyall-cause mortalityFemaleCardiology and Cardiovascular MedicineHumanAdultmedicine.medical_specialtyMean arterial pressurehypertensioncollaborative trial acctpulse wave velocityhypertension; intermediate cardiovascular phenotypes; intimamedia thickness; left ventricular hypertrophy; pressure; pulse wave analysis; pulse wave velocity; Adult; Cohort Studies; Female; Humans; Hypertension; Male; Middle Aged; Phenotype; Blood Pressure; Heart Rate; Internal Medicine; Physiology; Cardiology and Cardiovascular Medicinebrachial blood-pressurewave reflectionsteady component03 medical and health sciencesintermediate cardiovascular phenotypeInternal medicineHeart ratemedicineInternal MedicineHumansintima-media thicknessintimamedia thicknebusiness.industrymedicine.diseaseintimamedia thicknessBlood pressureIntima-media thicknessArterial stiffnessCohort Studiebusiness
researchProduct